About Conference
Experts in Hepatology from the University of Michigan Medical School will present a half-day program for physicians and other healthcare providers that outlines the most current treatment information for patients with liver diseases and complications. Combining case-based information, research studies, and common practice, presentations and question and answer panels will focus on challenges seen in liver care.
Highlights
utilize the latest developments in the diagnosis, staging, and treatment of metabolic-associated steatotic liver disease (MASLD), identify new developments in the diagnosis and treatment of cholestatic, autoimmune, and genetic liver diseases, implement new treatments including the use of immunotherapies for hepatocellular carcinoma.
Find on Map
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care
2.
FDA approves Blenrep for relapsed or refractory multiple myeloma
3.
X-ray and radar technology combined to reduce cancer screening risks
4.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
5.
Researchers discuss HER2-low and HER2-zero in breast cancer
1.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
2.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
3.
The New Era of Oncology: Key Updates and Clinical Insights
4.
HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option
5.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
Recommended News For You
1.
Thriving while surviving: Understanding the social needs of cancer survivors
2.
Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes
3.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
4.
Study identifies new target for obesity-related breast cancer
5.
Lentiviral Gene Therapy Shows Promise in Severe Hemophilia A
Conferences That Might Interest You
Recommended Articles For You
1.
Introduction to Immune Thrombocytopenic Purpura
2.
The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late
3.
Unraveling the Mysteries of Lymphoma: A Journey into the Unknown
4.
Octreotide's Efficacy in Reducing Transfusion Requirements in Angiodysplasia Bleeding
5.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
Boost Your Knowledge With These Quizzes
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge